Milestone Pharmaceuticals (MIST) EPS (Basic) (2018 - 2022)
Milestone Pharmaceuticals' (MIST) quarterly EPS (Basic) came in at -$0.34 in Q3 2022, down 1.6% on a YoY basis from -$0.35 in Q3 2021, and up 13.0% quarter-over-quarter from -$0.39 in Q2 2022.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) EPS (Basic) (2018 - 2022) Analysis & Trends
Milestone Pharmaceuticals (MIST) has reported EPS (Basic) for 5 consecutive years, with -$0.34 the latest figure, recorded in Q3 2022.
- For the quarter ending Q3 2022, EPS (Basic) fell 1.6% year-over-year to -$0.34; the trailing twelve-month figure through Sep 2022 stood at -$1.47 (down 78.63% YoY), and the FY2021 full-year result was -$1.02, up 39.84% from the prior year.
- EPS (Basic) advanced to -$0.34 in Q3 2022 per MIST's latest filing, from -$0.39 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.02 in Q2 2021 and bottomed at -$30.44 in Q4 2018.
- Historically, EPS (Basic) has averaged -$5.7 across 5 years, with a median of -$0.53 in 2019.
- The sharpest annual moves came in 2021 and 2022: EPS (Basic) jumped 103.51% in 2021, then slumped 2231.13% in 2022.
- Over 5 years, EPS (Basic) stood at -$30.44 in 2018, then soared by 96.19% to -$1.16 in 2019, then surged by 74.51% to -$0.3 in 2020, then sank by 36.67% to -$0.4 in 2021, then grew by 15.12% to -$0.34 in 2022.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.34, -$0.39, and -$0.4 for Q3 2022, Q2 2022, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Milestone Pharmaceuticals | 146.32 Mn | -25.18 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -0.34 |
| Jun 30, 2022 | -0.39 |
| Dec 31, 2021 | -0.40 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | 0.02 |
| Mar 31, 2021 | -0.30 |
| Dec 31, 2020 | -0.30 |
| Sep 30, 2020 | -0.40 |
| Jun 30, 2020 | -0.53 |
| Mar 31, 2020 | -0.67 |
| Dec 31, 2019 | -1.16 |
| Sep 30, 2019 | -0.52 |
| Jun 30, 2019 | -1.04 |
| Mar 31, 2019 | -17.33 |
| Dec 31, 2018 | -30.44 |
| Sep 30, 2018 | -20.16 |
| Jun 30, 2018 | -12.71 |
| Mar 31, 2018 | -15.57 |